LAM RESEARCH CORP·4

Jul 6, 12:33 PM ET

ARCHER TIMOTHY 4

4 · LAM RESEARCH CORP · Filed Jul 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Lam Research CEO Timothy Archer Sells 30,000 Shares

What Happened
Timothy Archer, President & CEO of Lam Research (LRCX), exercised 30,000 options (strike/consideration $30.03) to acquire shares and immediately sold 30,000 shares in an open-market transaction on July 2, 2026. The exercise cost was $900,990 (30,000 × $30.03); the subsequent sale fetched approximately $11,700,300 (30,000 × $390.01). The filing also shows a separate derivative disposition of 30,000 shares at $0 on the same date (see Key Details).

Key Details

  • Transaction date: July 2, 2026
  • Exercise: 30,000 shares acquired at $30.03 — total $900,990
  • Sale: 30,000 shares sold on open market at $390.01 — proceeds ~$11,700,300
  • Derivative disposition: 30,000 shares reported disposed at $0 (filing does not fully explain this line)
  • Shares owned after transaction: Not specified in the filing
  • Footnotes from filing:
    • F1: Trade effected pursuant to a Rule 10b5-1 trading plan adopted Feb 24, 2026
    • F2: Reported amount includes shares subject to unvested restricted stock units
    • F3: The stock options referenced became exercisable in three installments (03/02/2021, 03/02/2022, 03/02/2023)
  • Filing date: July 6, 2026 (reports the July 2 transaction)

Context
This was an exercise of options followed by an immediate sale of the resulting shares — effectively a cashless exercise and sale on the same day. The sale was made under a pre-established 10b5-1 plan, which typically means the trade was preplanned rather than a discretionary, on-the-spot decision. The filing does not indicate any late-reporting flag.

Insider Transaction Report

Form 4
Period: 2026-07-02
ARCHER TIMOTHY
President and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-07-02$30.03/sh+30,000$900,9901,105,966 total
  • Sale

    Common Stock

    [F1][F2]
    2026-07-02$390.01/sh30,000$11,700,3001,075,966 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F3]
    2026-07-0230,00091,400 total
    Exercise: $30.03Exp: 2027-03-02Common Stock (30,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    48,025.745
  • Common Stock

    (indirect: By Spouse)
    5,670.026
Footnotes (3)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026.
  • [F2]The amount reported includes shares subject to unvested restricted stock units.
  • [F3]The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Signature
Marta Woods by Power of Attorney|2026-07-06

Documents

1 file
  • 4
    wk-form4_1783355605.xmlPrimary

    FORM 4